StockData
Kura Oncology, Inc. logo

Kura Oncology, Inc. (KURA) stock

KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$7.35+0.01 (+0.14%)

Close on Nov 19, 2026Market cap $653.86MP/E –Yield –

Kura Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Kura Oncology's price to book ratio was 14.2× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 1.2× to 23.2×, with a median of 2.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.2×+10.5
2025Dec 31, 20253.7×+2.1
2024Dec 31, 20241.6×−0.9
2023Dec 29, 20232.5×+0.5
2022Dec 30, 20222.0×+0.2
2021Dec 31, 20211.7×−4.3
2020Dec 31, 20206.0×+3.4
2019Dec 31, 20192.7×−0.4
2018Dec 31, 20183.1×−1.9
2017Dec 29, 20175.0×+3.2
2016Dec 30, 20161.8×−0.7
2015Dec 31, 20152.4×–

More Kura Oncology figures

See a number that looks wrong?